Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Highlights from the Symptoms and Survivorship track at ASCO 2022

Stephanie B. Dixon • 5 Jun 2022
ASCO 2022
General

Stephanie B. Dixon, MD, St. Jude Children’s Research Hospital, Memphis, talks on what she was most excited for from the Symptoms and Survivorship track at ASCO 2022. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Stephanie B. Dixon

Will improving lifestyle choices prevent risk of death in childhood cancer survivors?
0:42
Will improving lifestyle choices prevent risk of death in childhood cancer survivors?
Stephanie B. Dixon • 5 Jun 2022
Unanswered questions in the management of childhood cancer survivors
0:46
Unanswered questions in the management of childhood cancer survivors
Stephanie B. Dixon • 5 Jun 2022
A report on modifiable risk factors for late mortality among five-year survivors of childhood cancer
1:22
A report on modifiable risk factors for late mortality among five-year survivors of childhood cancer
Stephanie B. Dixon • 5 Jun 2022

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026
The content of VJOncology is intended for healthcare professionals